Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.
Cancer Med
; 12(12): 13352-13360, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37156624
Full text:
1
Database:
MEDLINE
Main subject:
Rectal Neoplasms
/
Neoplasms, Second Primary
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Cancer Med
Year:
2023
Type:
Article
Affiliation country:
China